SCHEMBL21067352

SCHEMBL21067352

COc1ccccc1/C=C/C(=O)C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 3/20 0.72
TFEB P19484 1/20 0.72
KDM4E B2RXH2 2/20 0.70
MAPT P10636 4/20 0.69
NPC1 O15118 3/20 0.69
RAB9A P51151 2/20 0.69
LMNA P02545 2/20 0.69
BCHE P06276 1/20 0.69
MAPK1 P28482 2/20 0.62
ATM Q13315 1/20 0.62
NPSR1 Q6W5P4 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
LY96 Q9Y6Y9 1/20 0.60
MAOB P27338 3/20 0.59
AR P10275 1/20 0.59
CYP1A2 P05177 3/20 0.57
CYP2D6 P10635 3/20 0.57
HPGD P15428 3/20 0.57
CYP1A1 P04798 2/20 0.57
CYP1B1 Q16678 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30842599 1.00 NFE2L2 (0.72) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL21067353 1.00 NFE2L2 (0.72) NFE2L2TFEBKDM4EMAPTNPC1
Coumarinic Acid Methyl Ether SCHEMBL29369917 0.86 NFE2L2 (0.77) NFE2L2TFEBKDM4EMAPTNPC1
Coumarinic Acid Methyl Ether SCHEMBL79060 0.86 NFE2L2 (0.77) NFE2L2TFEBKDM4EMAPTNPC1
Coumarinic Acid Methyl Ether SCHEMBL83064 0.86 NFE2L2 (0.77) NFE2L2TFEBKDM4EMAPTNPC1
Coumarinic Acid Methyl Ether SCHEMBL714857 0.86 NFE2L2 (0.77) NFE2L2TFEBKDM4EMAPTNPC1
SCHEMBL6844089 0.85 NFE2L2 (0.74) NFE2L2MAPTNPC1RAB9ALMNA
SCHEMBL6844087 0.85 NFE2L2 (0.74) NFE2L2MAPTNPC1RAB9ALMNA
Coumarinic Acid Methyl Ether SCHEMBL10437229 0.84 NFE2L2 (0.74) NFE2L2TFEBKDM4EMAPTNPC1
Coumarinic Acid Methyl Ether SCHEMBL4743620 0.84 NFE2L2 (0.74) NFE2L2TFEBKDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117902981-A Synthesis method of (E) -4-o-methoxyphenyl-2-oxo-3-ethyl butenoate 兴义民族师范学院 2024-04-19 CN disclosed
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed